À¯¹æ¾Ï ȯÀÚÀÇ ¸ö°ú ¸¶À½±îÁö Ä¡À¯ÇÏ´Â Á¾¾ç¼ºÇü¼úÀÇ ´ë°¡
ÁÖ¿ä Àü¹®ºÐ¾ß´Â À¯¹æ¾ÏÀ¸·Î ¾Ç¼º Á¾¾çÀ» ÀýÁ¦ÇÏ°í ³²¾ÆÀÖ´Â À¯¹æ Á¶Á÷À» ÀÌ¿ëÇØ ÈäÅ͸¦ ÃÖ¼ÒÈÇÏ´Â 'Á¾¾ç¼ºÇü¼ú' ºÐ¾ßÀÇ ±¹³» ±ÇÀ§ÀÚ´Ù. À¯¹æ¾ÏÀ» ºñ·ÔÇÑ À¯¹æ ¼ö¼úÀ» 4500·Ê ÀÌ»ó ÁýµµÇÏ¿´À¸¸ç, À¯¹æ¾Ï ȯÀÚÀÇ ÀÔÀå¿¡¼ ¿©¼ºÀÇ »ó½Ç°¨Àº ÁÙÀÌ°í »îÀÇ ÁúÀ» ³ôÀÌ´Â °ÍÀÌ ±×¸¸ÀÇ Áø·á öÇÐÀÌ´Ù.
| Á¦ ¸ñ | Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | Cell Rep |
| Á¦ ¸ñ | Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer?The BRAIN Study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | cancers |
| Á¦ ¸ñ | »îÀÇ ¸ñÀû°ú °Ç° °ü·Ã »îÀÇ Áú°úÀÇ ¿¬°ü¼º: À¯¹æ¾Ï ȯÀÚ¿¡¼ÀÇ ´Ü¸é¿¬±¸ | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | ½Å¾Ó°ú Çй® |
| Á¦ ¸ñ | Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment:A population-based study in Korea by the SMARTSHIP group | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | The Breast |
| Á¦ ¸ñ | Physicians' Awareness of the Breast Cancer Survivors' Unmet Needs in Korea | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Journal of Breast Cancer |
| Á¦ ¸ñ | Current practices toward fertility issue for young breast cancer Patients:A survey of the Korean breast cancer society;The SMARTSHIP study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | Journal of Breast disease |
| Á¦ ¸ñ | The Clinical Impact of Body Mass Index on Breast Cancer in Korea: A Nationwide Population-Based Cohort Study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | Journal of Breast disease |

°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿øÀº °¡Å縯±³È¸ Á¤½ÅÀÎ ±×¸®½ºµµÀÇ ÀǼú·Î ÀηùÀÇ ¾ÆÇ ¸ö°ú ¸¶À½À» Ä¡À¯ÇÑ´Ù´Â ¹Ì¼Ç ¾Æ·¡ ¼³¸³µÆ´Ù. ÀÎõ±¹Á¦°øÇ×°ú °¡Àå °¡±î¿î ´ëÇѹα¹ÀÇ °ü¹® º´¿øÀÌÀÚ, ÀÎõ ¼±¸¿Í ¿µÁ¾µµ, °È, ±èÆ÷ Áö¿ª ÃÖÃÊ-À¯ÀÏÀÇ ´ëÇк´¿øÀÌ´Ù. ½ÉÀåÇ÷°ü¼¾ÅÍ, ·Îº¿¼ö¼ú¼¾ÅÍ, °ÅÁ¡Áö¿ª ÀÀ±ÞÀÇ·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹® ¼¾Å͸¦ ¿î¿µÇϸç ÁßÁõÀÀ±ÞÁúȯ Ä¡·á¿¡ Èû¾²°í ÀÖ´Ù.
ÀÎõ±¤¿ª½Ã ¼±¸ ½É°î·Î 100¹ø±æ 25